Finanzen von Ocugen Inc (OCGN)OCGNOcugen Inc

Evaluating the bottom line, Ocugen, Inc. maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -1105.11%, while the net margin is -1671.84%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively OCGN converts its operational activities into shareholder value.

In the context of the broader market, OCGN competes directly with industry leaders such as ABEO and AMRN. With a market capitalization of $250.84M, it holds a significant position in the sector. When comparing efficiency, OCGN's gross margin of 100.00% stands against ABEO's 63.30% and AMRN's 35.51%. Such benchmarking helps identify whether Ocugen, Inc. is trading at a premium or discount relative to its financial performance.

Ocugen's financial performance shows a troubling trend with consistent net losses, including -$24,877,000 in Q2 2026. The gross margin remains high at 100%, but this is overshadowed by the negative net income and declining equity.